Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines

Clinical and Translational Oncology

Volumn 13, Issue 8, 2011, Pages 536-544

  Feliu, Jaime ^a   Sastre, Javier ^b   Maurel, Joan ^c   Isla, Dolores ^d  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Biliary tract carcinoma; Guidelines; Hepatocellular carcinoma; Multidisciplinary treatment

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; OXALIPLATIN; PLACEBO; SORAFENIB; YTTRIUM 90; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; ASPIRATION BIOPSY; BILE DUCT CARCINOMA; BILIARY CIRRHOSIS; BILIARY TRACT BIOPSY; BILIARY TRACT DRAINAGE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTECTOMY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DIAGNOSTIC ACCURACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LYMPHADENECTOMY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PALLIATIVE THERAPY; PARTIAL HEPATECTOMY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; TREATMENT INDICATION; ALGORITHM; BILIARY TRACT TUMOR; BIOPSY; EARLY DIAGNOSIS; MEDICAL SOCIETY; METHODOLOGY; ONCOLOGY;

ALGORITHMS; ANTINEOPLASTIC AGENTS; BILIARY TRACT NEOPLASMS; BIOPSY; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; HUMANS; MEDICAL ONCOLOGY; NEOPLASM STAGING; SOCIETIES, MEDICAL;

EID: 84855361543     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0694-x     Document Type: Article

References (20)

1. Ferlay J, Parkin DM, Pisani P (2010) GLOBOCAN 2009:cancer incidence and mortality worldwide: IARC Cancer Base No. 10. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr
2. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417-422
3. Forner A, Ayuso C, Real MI et al (2009) Diagnosis and treatment of hepatocellular carcinoma. Med Clin 132:272-286
4. Jelic S, Sotiropoulos GC (2010) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21[Suppl 5]:v59-v64
5. NCCN (2010) Hepatobiliary Cancers. NCCN Practice Guidelines in Oncology v.1.2010
6. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236 (Pubitemid 43112690)
7. Dong J, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7:448-458
8. Llovet J, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329-338
9. Forner A, Reig ME, Rodríguez-Lope C et al (2010) Current strategy for staging and treatment: the CCLC update and future prospects. Semin Liver Dis 1:61-74
10. Thomas MB, Jaffe D, Choti MM et al (2010) Hepatocellular carcinoma: consensus recomendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 28:3994-4005
11. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390
12. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomized, double-blind, placebo-controlled trial. Lancet Oncol 10:25-34
13. Peck-Radosavljevic M, Greten TF, Lammer J et al (2010) Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 22:391-398
14. Eckel F, Brunner T, Jelic S (2010) Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol [Suppl 6]:v65-v69
15. Aljiffry M, Wlash MJ, Molinari M (2009) Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 15:4240-4262
16. Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308-321 (Pubitemid 351975555)
17. Miyakawa S, Ishihara S, Takada T et al (2008) Flowchart for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 15:7-14 (Pubitemid 351279836)
18. Mosconi S, Beretta GD, Labianca R et al (2009) Cholangiocarcinoma. Crit Rev Oncol Hematol 69:259-270
19. Glimelius B, Hoffman K, Sjöden PO et al (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7:593-600 (Pubitemid 26285639)
20. Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281